About this trial
The DIPLOMA-3 trial is an international, multicenter, patient-blinded randomized controlled trial comparing laparoscopic and robot-assisted left-sided pancreatectomy. Patients with an indication for elective left-sided pancreatecomy for benign or premalignant lesions in the body or tail of the pancreas and considered eligible will be randomized between laparoscopic and robot-assisted resection.
Eligibility criteria
Qualifiers
Age at least 18 years;
Indication for elective left-sided pancreatectomy, either spleen-preserving or non-preserving (because of proven or suspected left-sided benign or premalignant disease);
Both robot-assisted and laparoscopic left-sided pancreatectomy are technically feasible for resection, according to the local treatment team;
Fit to undergo left-sided pancreatectomy according to the surgeon and anaesthesiologist;
Disqualifiers
Suspected pancreatic ductal adenocarcinoma;
Tumor or cyst larger than 8 cm;
Required resection or ablation of organs other than pancreas and spleen;
Tumor involvement or abutment of major vessels (celiac trunk, mesenteric artery or vena cava);
Trial design
Treatments tested in this trial
- Laparoscopic minimally invasive left-sided pancreatecomy
- Robot-assisted minimally invasive left-sided pancreatecomy
Treatment groups
Sponsors and collaborators
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead sponsor
Leiden University Medical Center
Collaborator
Catharina Ziekenhuis Eindhoven
Collaborator
Erasmus Medical Center
Collaborator
Medisch Spectrum Twente
Collaborator
Maastricht University Medical Center
Collaborator
University Medical Center Groningen
Collaborator
Onze Lieve Vrouwe Gasthuis
Collaborator